肝纤维化治疗的研究进展  

Research progress in treatment of liver fibrosis

作　　者：凌清儿(综述) 张戎(审校)[2] LING Qinger;ZHANG Rong(The First Clinical Medical College of Nanjing Medical University,Nanjing,Jiangsu 210029,China;School of Medicine Basic sciences,Nanjing Medical University,Nanjing,Jiangsu 211166,China)

机构地区：[1]南京医科大学第一临床医学院,江苏南京210029 [2]南京医科大学基础医学院,江苏南京211166

出　　处：《现代医药卫生》2023年第11期1926-1931,共6页Journal of Modern Medicine & Health

摘　　要：肝纤维化是一种肝损伤后的慢性修复反应。肝纤维化是肝损伤向肝硬化甚至肝癌发展的一个中间环节,并可以不断进展、叠加,严重影响患者的生命健康。同时,由于肝纤维化又无明显的临床症状,所以肝纤维化的诊断、治疗极其重要。目前,肝纤维化已经成为该领域的研究重点与热点。该文对目前肝纤维化的治疗进展进行综述。Liver fibrosis is a chronic repair reaction after liver injury.Liver fibrosis is an intermediate link in the development from liver injury to liver cirrhosis and even liver cancer.It can continuously be superimposed,which seriously affects the life and health of patients.At the same time,because liver fibrosis has no obvious clinical symptoms,the diagnosis and treatment of liver fibrosis are extremely important.At present,liver fibrosis has become the focus of research and hot spot in this field.This article reviews the treatment progress of liver fibrosis.

关 键 词：肝纤维化 肝纤维化诊断 肝纤维化治疗 

分 类 号：R45[医药卫生—治疗学]